MORGAN STANLEY - IMMUNOCORE HLDGS PLC ownership

IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 59 filers reported holding IMMUNOCORE HLDGS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of IMMUNOCORE HLDGS PLC
ValueSharesWeighting
Q3 2023$49,880,467
+2.4%
961,088
+18.3%
0.01%0.0%
Q2 2023$48,724,816
+23.7%
812,622
+2.0%
0.01%
+25.0%
Q1 2023$39,378,515
+94.5%
796,491
+124.5%
0.00%
+100.0%
Q4 2022$20,243,984
+188.0%
354,722
+136.9%
0.00%
+100.0%
Q3 2022$7,029,000
+707.0%
149,750
+541.4%
0.00%
Q2 2022$871,000
+1144.3%
23,347
+892.6%
0.00%
Q1 2022$70,000
+45.8%
2,352
+67.4%
0.00%
Q4 2021$48,000
-44.2%
1,405
-39.5%
0.00%
Q3 2021$86,000
+8500.0%
2,321
+11505.0%
0.00%
Q2 2021$1,000
-99.8%
20
-99.9%
0.00%
Q1 2021$648,00015,2070.00%
Other shareholders
IMMUNOCORE HLDGS PLC shareholders Q1 2022
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 576,923$28,523,07325.19%
Velan Capital Investment Management LP 200,000$9,888,0008.43%
RTW INVESTMENTS, LP 5,649,943$279,333,1825.82%
Paradigm Biocapital Advisors LP 1,126,256$55,682,0975.28%
Rock Springs Capital Management LP 3,001,662$148,402,1693.54%
Logos Global Management LP 500,000$24,720,0003.54%
TANG CAPITAL MANAGEMENT LLC 405,600$20,052,8642.99%
GREAT POINT PARTNERS LLC 255,367$12,625,3442.48%
COWEN AND COMPANY, LLC 405,174$20,031,8022.35%
Eschler Asset Management LLP 60,000$2,966,4002.34%
View complete list of IMMUNOCORE HLDGS PLC shareholders